Brazil continues pharmacopoeia revision
This article was originally published in Scrip
Executive Summary
ANVISA, Brazil's medicines agency, is continuing to update the national pharmacopoeia with new quality standards for 22 medicinal plants and derivatives used to produce pharmaceuticals.